Search earnings tickers

BMY

2024Q2BMO

Bristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-07-26 · Fiscal end 2024-06-30 · Features as of 2024-07-25

← Earnings history

Street

Consensus EPS1.63

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.9%

IV front—

P/C full—

P/C front—

Features as of2024-07-25

Run-up

Close—

Ret 5d+6.8%

Ret 10d+11.1%

Ret 20d+6.5%

Ret 30d+5.2%

Print

Actual EPS

2.07Beat

Estimated EPS1.63

Actual revenue

12.2B

Surprise %+27.0%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction+4.5%

Implied vs actual

Implied 1.9%Actual 6.6%

Gap reaction+6.6%

Day result+11.4%

Next-day upYes

Realized / IV3.51×

Post tape

Post 5d-3.3%

Post 10d-7.4%

Post volume36.6M

Vol ×10d2.16×

Vol ×20d2.27×

Post range6.0%

BMY

Pre-Earnings Data